Tachyarrhythmia |
Key ICD Trials
Recent large prospective, randomized clinical trials (MADIT, AVID, CIDS, CASH, MUSTT, and MADIT II and SCD-HeFT) confirmed the efficacy of the ICD as first-line therapy for patients with ventricular tachyarrhythmias and for high-risk, post-MI and heart failure patients.
Primary Prevention Trials
ICD VS. Anitiarrythmic Drug Treatment and placebo in heart failure and Post-MI Patients
Primary Prevention TrialsAdditional Information
|
©Medtronic, Inc. 2008 • Contact Medtronic • Privacy Statement • Terms of Use • Site Map